Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prediction of cancer-associated thrombosis by machine learning: results from the Vienna Cancer and Thrombosis Study.

ESMO open·2026

Same author

Peripheral blood DNA methylation profile and immune checkpoint inhibitor response in cancer patients.

ESMO open·2026

Same author

Absolute quantitative proteomics identifies patterns of plasma proteins associated with venous thromboembolism in patients with colorectal cancer.

Thrombosis research·2026

Same author

Predictive potential of patient-specific immunological characteristics in solid cancers: circulating monocytes, myeloid-derived suppressor cells, T cells, and the T-cell receptor repertoire.

ESMO open·2026

Same author

Venous thromboembolic event risk with PARP inhibitors in solid tumors: a systematic review and meta-analysis.

ESMO open·2025

Same author

Optimal approach to performing and reporting computed tomography angiography for suspected acute pulmonary embolism: a clinical consensus statement of the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, the Fleischner Society, the Association for Acute CardioVascular Care (ACVC) and the European Association of Cardiovascular Imaging (EACVI) of the ESC, endorsed by European Respiratory Society (ERS), Asian Society of Thoracic Radiology (ASTR), European Society of Thoracic Imaging (ESTI), and Society of Thoracic Radiology (STR).

European heart journal. Cardiovascular Imaging·2025

Same journal

Cardiovascular disease and miRNA.

Advances in clinical chemistry·2026

Same journal

RNA biomarkers in antidoping.

Advances in clinical chemistry·2026

Same journal

Biomarkers for assessing magnesium status.

Advances in clinical chemistry·2026

Same journal

Advances in microfluidic extracellular vesicle technology.

Advances in clinical chemistry·2026

Same journal

Chronic low-grade inflammation in vegetarians and vegans: Biomarker evidence and methodological considerations.

Advances in clinical chemistry·2026

Same journal

Biomarkers in heart failure.

Advances in clinical chemistry·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 28, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

D-dimer testing: A narrative review.

L Wauthier¹, J Favresse², M Hardy³

¹Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.

Advances in Clinical Chemistry

|June 2, 2023

Summary

This summary is machine-generated.

D-dimer is a biomarker for blood clot formation and breakdown, primarily used to rule out venous thromboembolism (VTE). This review covers D-dimer

Keywords:

Acute aortic syndrome (AAS)Analytic COVID-19 Cancer D-dimer Disseminated intravascular coagulation Postanalytic Preanalytic Pregnancy Venous thromboembolism

More Related Videos

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

Related Experiment Videos

Last Updated: Jul 28, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

Area of Science:

Biochemistry
Hematology
Clinical Diagnostics

Background:

D-dimer represents fibrin degradation products, indicating activation of coagulation and fibrinolysis.
Its primary clinical utility lies in excluding venous thromboembolism (VTE).
D-dimer is also explored for VTE recurrence risk, anticoagulation duration, disseminated intravascular coagulation (DIC) diagnosis, and VTE risk screening.

Conclusions:

D-dimer is a valuable diagnostic tool, particularly for ruling out VTE.
Standardized assay performance and appropriate interpretation are crucial for reliable results.
Further research is needed to optimize D-dimer use in specific clinical scenarios like pregnancy, cancer, and COVID-19.